ABOUT US OPERATIONS CSR INVESTORS MEDIA CAREERS CONTACT US العربية INVESTORS / INVESTORS HOME INVESTMENT CASE SHARE INFORMATION RESULTS CENTER FINANCIAL STATEMENTS REGULATORY NEWS OTHER NEWS REPORTS AND PRESENTATIONS ANALYST COVERAGE LISTING INFORMATION SHARE TRANSFER MECHANISM AND DOCUMENTS ARBITRATION DOCUMENTS CONTACTS ABOUT US IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria and is proudly woman-led. A long track record for quality and safety has earned the Group a trusted reputation, as well as internationally-recognised accreditations for its portfolio of over 2,000 diagnostics tests. From its base of over 400 branches, the Company will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. One of IDH’s philosophies is its strict adherence to providing accurate and timely diagnostic services, which is why we accredit our laboratories through stringent international bodies such as College of American Pathologists (CAP) and the International Organization for Standardization (ISO). The Company remains committed to its core values of providing patient-focused care, supporting and enhancing its medical staff’s education and training, acquiring and sharing information effectively, while developing and strengthening its relationships with patients employees and business partners. IDH is also bound to its ethical values that emphasize integrity and fairness, as it strives for superior operational and financial performance. IDHC LSE USD 1.34 + 3.08 % LAST TRADED 01/12/2021 05:13 PM EGX EGP 19.00 0.00 % LAST TRADED 30/11/2021 10:13 AM MORE DETAILS LATEST LINKS EARNINGS RELEASE INVESTOR RELATIONS PRESENTATION ANNUAL REPORT © IDHCorp - Integrated Diagnostics Holding © 2021